Matthew Pace
James Martin Research Fellow
I received my PhD in Cell and Molecular Biology from the University of Pennsylvania. I am currently studying the role natural killer cells have on HIV reservoir size and post treatment control.
Recent publications
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
Journal article
Frater J. et al, (2021), The Lancet HIV, 8, e474 - e485
-
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation.
Journal article
Gupta RK. et al, (2019), Nature, 568, 244 - 248
-
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
Journal article
Gossez M. et al, (2019), AIDS, 33, 185 - 197
-
A randomised controlled trial comparing the impact of antiretroviral therapy (ART) with a "Kick-and-Kill" approach to ART alone on HIV reservoirs in individuals with primary HIV infection (PHI); RIVER trial
Conference paper
Fidler S. et al, (2018), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 21, 155 - 155
-
Follicular CD8+T-cells in gut-associated lymphoid tissue are associated with lower HIV-1 reservoir in the terminal ileum after ART initiated during primary HIV infection
Conference paper
Thornhill JP. et al, (2018), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 21, 96 - 96